gms | German Medical Science

66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Friendship Meeting mit der Italienischen Gesellschaft für Neurochirurgie (SINch)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

7. - 10. Juni 2015, Karlsruhe

Increasing numbers of non-aneurysmal subarachnoid hemorrhage – antithrombotic medication as reason and prognostic factor

Meeting Abstract

  • Jürgen Konczalla - Klinik für Neurochirurgie, Goethe-Universitätsklinikum, Frankfurt am Main
  • Sepide Kashefiolasl - Klinik für Neurochirurgie, Goethe-Universitätsklinikum, Frankfurt am Main
  • Nina Brawanski - Klinik für Neurochirurgie, Goethe-Universitätsklinikum, Frankfurt am Main
  • Christian Senft - Klinik für Neurochirurgie, Goethe-Universitätsklinikum, Frankfurt am Main
  • Volker Seifert - Klinik für Neurochirurgie, Goethe-Universitätsklinikum, Frankfurt am Main
  • Johannes Platz - Klinik für Neurochirurgie, Goethe-Universitätsklinikum, Frankfurt am Main

Deutsche Gesellschaft für Neurochirurgie. 66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC). Karlsruhe, 07.-10.06.2015. Düsseldorf: German Medical Science GMS Publishing House; 2015. DocP 151

doi: 10.3205/15dgnc549, urn:nbn:de:0183-15dgnc5499

Veröffentlicht: 2. Juni 2015

© 2015 Konczalla et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Objective: Subarachnoid hemorrhage (SAH) is usually caused by a ruptured intracranial aneurysm, but in some patients no source of hemorrhage can be detected. More recent data showed increasing numbers of spontaneous non-aneurysmal SAH (non-aSAH). Our objective was to analyze factors, especially patients using systemic anticoagulation and/or antiplatelet medication (aCP+), influencing the increasing numbers and the clinical outcome.

Method: Between 1999 and 2013 214 patients suffered from non-aSAH, 14% of all patients with SAH. Outcome was assessed according to the modified Rankin Scale (mRS) at 6 months. Risk factors were identified based on the outcome.

Results: We identified increasing numbers of patients with non-aSAH. Over the periods the rate of perimesencephalic (PM) SAH decreased, whereas the rate of non-PM (NPM) SAH increased. The rate of aCP+ increased statistically significant. Favorable outcome (mRS 0 - 2) was achieved in 85%, but aCP+ patients had a significant higher risk for an unfavorable outcome. The further analysis showed that especially the subgroup of 'Fisher 3 bleeding pattern' had a high risk for an unfavorable outcome, whereas the subgroup NPM-SAH without Fisher 3 bleeding pattern had a similar favorable outcome like PM-SAH.

Conclusions: Due to changes of patients' admission in the last years we identified significant higher rates of aCP+ and therefore higher amounts of bleedings and worse outcome. Especially elderly patients with Fisher type 3 blood patterns and aCP+ were at risk for unfavorable outcome. Therefore, for further investigations NPM-SAH should be stratified into patients with or without Fisher 3 blood pattern.